Works matching AU Kumada, Takashi

Results: 273

The impact of HCV eradication by direct‐acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study.

Published in:

Liver International, 2019, v. 39, n. 3, p. 448, doi. 10.1111/liv.13987

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi;
Mizuno, Kazuyuki;
Sone, Yasuhiro;
Akita, Tomoyuki;
Tanaka, Junko;
Johnson, Philip J.

Publication type:

Article

Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead‐time bias.

Published in:

Liver International, 2018, v. 38, n. 12, p. 2260, doi. 10.1111/liv.13927

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi;
Mizuno, Kazuyuki;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Akita, Tomoyuki;
Tanaka, Junko

Publication type:

Article

Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.

Published in:

Liver International, 2018, v. 38, n. 3, p. 484, doi. 10.1111/liv.13670

By:

the Liver Cancer Study Group of Japan;
Takayasu, Kenichi;
Takayama, Tadatoshi;
Ku, Yonson;
Kumada, Takashi;
Kubo, Shoji;
Kokudo, Takashi;
Kokudo, Norihiro;
Arii, Shigeki;
Sakamoto, Michiie;
Matsuyama, Yutaka;
Hagiwara, Yasuhiro;
Kudo, Masatoshi;
Kaneko, Shuichi;
Nakashima, Osamu;
Kadoya, Masumi;
Izumi, Namiki

Publication type:

Article

Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.

Published in:

Liver International, 2016, v. 36, n. 6, p. 817, doi. 10.1111/liv.13071

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Kiriyama, Seiki;
Tanikawa, Makoto;
Hisanaga, Yasuhiro;
Kanamori, Akira;
Kitabatake, Shusuke;
Yama, Tsuyoki;
Tanaka, Junko

Publication type:

Article

Response to 'WFA<sup>+</sup>-M2BP: a novel biomarker with diagnostic and therapeutic implications in liver diseases'.

Published in:

Liver International, 2016, v. 36, n. 4, p. 613, doi. 10.1111/liv.13044

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi

Publication type:

Article

Serum WFA<sup>+</sup>-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.

Published in:

Liver International, 2016, v. 36, n. 2, p. 293, doi. 10.1111/liv.12907

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi;
Kaneoka, Yuji;
Maeda, Atsuyuki;
Korenaga, Masaaki;
Mizokami, Masashi;
Narimatsu, Hisashi

Publication type:

Article

Incidence of hepatocellular carcinoma and response to interferon therapy in HCV-infected patients: effect of factors associated with the therapeutic response and incidence of HCC.

Published in:

Liver International, 2012, v. 32, n. 6, p. 1029, doi. 10.1111/j.1478-3231.2012.02763.x

By:

Toyoda, Hidenori;
Kumada, Takashi

Publication type:

Article

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.

Published in:

Liver International, 2011, v. 31, n. 9, p. 1359, doi. 10.1111/j.1478-3231.2011.02571.x

By:

Hayashi, Kazuhiko;
Katano, Yoshiaki;
Honda, Takashi;
Ishigami, Masatoshi;
Itoh, Akihiro;
Hirooka, Yoshiki;
Ishikawa, Tetsuya;
Nakano, Isao;
Yoshioka, Kentaro;
Toyoda, Hidenori;
Kumada, Takashi;
Goto, Hidemi

Publication type:

Article

Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

Published in:

Liver International, 2010, v. 30, n. 4, p. 527, doi. 10.1111/j.1478-3231.2009.02064.x

By:

Honda, Takashi;
Katano, Yoshiaki;
Shimizu, Junichi;
Ishizu, Yoji;
Doizaki, Masao;
Hayashi, Kazuhiko;
Ishigami, Masatoshi;
Itoh, Akihiro;
Hirooka, Yoshiki;
Nakano, Isao;
Urano, Fumihiro;
Yoshioka, Kentaro;
Toyoda, Hidenori;
Kumada, Takashi;
Goto, Hidemi

Publication type:

Article

Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological response.

Published in:

Liver International, 2009, v. 29, n. 1, p. 120, doi. 10.1111/j.1478-3231.2008.01736.x

By:

Toyoda, Hidenori;
Kumada, Takashi;
Kiriyama, Seiki;
Sone, Yasuhiro;
Tanikawa, Makoto;
Hisanaga, Yasuhiro;
Kanamori, Akira;
Atsumi, Hiroyuki;
Nakano, Satoshi;
Arakawa, Takahiro

Publication type:

Article

Relationship between Lens culinaris agglutinin-reactive α-fetoprotein and pathologic features of hepatocellular carcinoma.

Published in:

Liver International, 2005, v. 25, n. 4, p. 848, doi. 10.1111/j.1478-3231.2005.01111.x

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Kiriyama, Seiki;
Sone, Yasuhiro;
Tanikawa, Makoto;
Hisanaga, Yasuhiro;
Kitabatake, Shusuke;
Kuzuya, Teiji;
Nonogaki, Koji;
Shimizu, Junichi;
Yamaguchi, Akihiro;
Isogai, Masatoshi;
Kaneoka, Yuji;
Washizu, Junji;
Satomura, Shinji

Publication type:

Article

Assessment of tumor hemodynamics in small hepatocellular carcinoma: comparison of Doppler ultrasonography, angiography-assisted computed tomography, and pathological findings.

Published in:

Liver International, 2004, v. 24, n. 5, p. 425, doi. 10.1111/j.1478-3231.2004.0932.x

By:

Kumada, Takashi;
Nakano, Satoshi;
Toyoda, Hidenori;
Hayashi, Kazuhiko;
Kiriyama, Seiki;
Sone, Yasuhiro;
Tanikawa, Makoto;
Hisanaga, Yasuhiro;
Yamamoto, Akiko;
Takeshima, Kenji;
Hibi, Toshio;
Yabashi, Toshitake;
Noda, Takahiro;
Sassa, Toshi;
Furukawa, Masakazu;
Ogawa, Sadanobu

Publication type:

Article

Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection.

Published in:

European Radiology, 2022, v. 32, n. 7, p. 5016, doi. 10.1007/s00330-022-08570-4

By:

Toyoda, Hidenori;
Yasuda, Satoshi;
Shiota, Shohei;
Sone, Yasuhiro;
Maeda, Atsuyuki;
Kaneoka, Yuji;
Kumada, Takashi;
Tanaka, Junko

Publication type:

Article

Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.

Published in:

European Radiology, 2014, v. 24, n. 9, p. 2157, doi. 10.1007/s00330-014-3254-2

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Ito, Takanori;
Sone, Yasuhiro;
Kaneoka, Yuji;
Maeda, Atsuyuki;
Okuda, Seiji;
Otobe, Katsuhiko;
Takahashi, Kenichi

Publication type:

Article

Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study.

Published in:

Oncology, 2025, v. 103, n. 6, p. 456, doi. 10.1159/000541018

By:

Persano, Mara;
Casadei-Gardini, Andrea;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Rossari, Federico;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Published in:

Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

Published in:

Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Toyoda, Hidenori;
Yasuda, Satoshi;
Tsuji, Kunihiko;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Tada, Toshifumi;
Takaguchi, Koichi;
Itobayashi, Ei;
Shimada, Noritomo;
Shibata, Hiroshi;
Tanaka, Takaaki;
Tsutsui, Akemi;
Nagano, Takuya;
Imai, Michitaka;
Nakamura, Shinichiro

Publication type:

Article

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

Published in:

Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Fukunishi, Shinya;
Ohama, Hideko;
Kawata, Kazuhito

Publication type:

Article

Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko;
Tsutsui, Akemi;
Itokawa, Norio

Publication type:

Article

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade.

Published in:

Oncology, 2016, v. 91, n. 3, p. 153, doi. 10.1159/000447061

By:

Hiraoka, atsushi;
Kumada, Takashi;
Nouso, Kazuhiro;
Tsuji, Kunihiko;
Itobayashi, Ei;
Hirooka, Masashi;
Kariyama, Kazuya;
Ishikawa, Toru;
Tada, Toshifumi;
Toyoda, Hidenori;
Kawasaki, Hideki;
Hiasa, Yoichi;
Michitaka, Kojiro

Publication type:

Article

Highly Sensitive Lens culinaris Agglutinin-Reactive α-Fetoprotein: A New Tool for the Management of Hepatocellular Carcinoma.

Published in:

Oncology, 2011, v. 81, p. 61, doi. 10.1159/000333263

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi

Publication type:

Article

Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 522, doi. 10.1159/000537915

By:

Rossari, Federico;
Tada, Toshifumi;
Suda, Goki;
Shimose, Shigeo;
Kudo, Masatoshi;
Yoo, Changhoon;
Cheon, Jaekyung;
Finkelmeier, Fabian;
Lim, Ho Yeong;
Presa, José;
Masi, Gianluca;
Bergamo, Francesca;
Amadeo, Elisabeth;
Vitiello, Francesco;
Kumada, Takashi;
Sakamoto, Naoya;
Iwamoto, Hideki;
Aoki, Tomoko;
Chon, Hong Jae;
Himmelsbach, Vera

Publication type:

Article

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Toyoda, Hidenori;
Kariyama, Kazuya;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Itobayashi, Ei;
Tsuji, Kunihiko;
Ishikawa, Toru;
Ohama, Hideko;
Tada, Fujimasa;
Nouso, Kazuhiro

Publication type:

Article

Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.

Published in:

Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 527, doi. 10.1159/000525145

By:

Casadei-Gardini, Andrea;
Rimini, Margherita;
Kudo, Masatoshi;
Shimose, Shigeo;
Tada, Toshifumi;
Suda, Goki;
Goh, Myung Ji;
Jefremow, Andre;
Scartozzi, Mario;
Cabibbo, Giuseppe;
Campani, Claudia;
Tamburini, Emiliano;
Tovoli, Francesco;
Ueshima, Kazuomi;
Aoki, Tomoko;
Iwamoto, Hideki;
Torimura, Takuji;
Kumada, Takashi;
Hiraoka, Atsushi;
Atsukawa, Masanori

Publication type:

Article

Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Published in:

Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 290, doi. 10.1159/000522403

By:

Kubo, Shoji;
Shinkawa, Hiroji;
Asaoka, Yoshinari;
Ioka, Tatsuya;
Igaki, Hiroshi;
Izumi, Namiki;
Itoi, Takao;
Unno, Michiaki;
Ohtsuka, Masayuki;
Okusaka, Takuji;
Kadoya, Masumi;
Kudo, Masatoshi;
Kumada, Takashi;
Kokudo, Norihiro;
Sakamoto, Michiie;
Sakamoto, Yoshihiro;
Sakurai, Hideyuki;
Takayama, Tadatoshi;
Nakashima, Osamu;
Nagata, Yasushi

Publication type:

Article

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355

By:

Atsushi Hiraoka;
Takashi Kumada;
Toshifumi Tada;
Kazuya Kariyama;
Joji Tani;
Shinya Fukunishi;
Masanori Atsukawa;
Masashi Hirooka;
Kunihiko Tsuji;
Toru Ishikawa;
Koichi Takaguchi;
Ei Itobayashi;
Kazuto Tajiri;
Noritomo Shimada;
Hiroshi Shibata;
Hironori Ochi;
Kazuhito Kawata;
Satoshi Yasuda;
Hidenori Toyoda;
Hideko Ohama

Publication type:

Article

EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Hiraoka, Atsushi;
Wakuta, Akiko;
Oonishi, Ayano;
Kuzuya, Teiji;
Toyoda, Hidenori;
Tada, Toshifumi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kudo, Masatoshi;
Kumada, Takashi

Publication type:

Article

Changes in Background Liver Function in Patients with Hepatocellular Carcinoma over 30 Years: Comparison of Child-Pugh Classification and Albumin Bilirubin Grade.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 518, doi. 10.1159/000507933

By:

Kumada, Takashi;
Toyoda, Hidenori;
Tada, Toshifumi;
Yasuda, Satoshi;
Tanaka, Junko

Publication type:

Article

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Yokohama, Keisuke;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya

Publication type:

Article

Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 41, doi. 10.1159/000502479

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Wakuta, Akiko;
Oonishi, Ayano;
Toyoda, Hidenori;
Tada, Toshifumi;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kumada, Takashi

Publication type:

Article

Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients. Authors' Reply

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1469, doi. 10.1111/apt.18319

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Kumada, Takashi

Publication type:

Article

Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Kawata, Kazuhito

Publication type:

Article

Changes in Hepatitis C Virus (HCV) Antibody Status in Patients with Chronic Hepatitis C after Eradication of HCV Infection by Interferon Therapy.

Published in:

Clinical Infectious Diseases, 2005, v. 40, n. 6, p. e49, doi. 10.1086/428128

By:

Toyoda, Hidenori;
Kumada, Takashi;
Kiriyama, Seiki;
Sone, Yasuhiro;
Tanikawa, Makoto;
Hisanaqa, Yasuhiro;
Kuzuya, Teiji;
Honda, Takashi;
Hayashi, Kazuhiko;
Nakano, Isao;
Katano, Yoshiaki;
Gob, Hidemi

Publication type:

Article

Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.

Published in:

2017

By:

Johnson, Philip;
Berhane, Sarah;
Kagebayashi, Chiaki;
Satomura, Shinji;
Teng, Mabel;
Fox, Richard;
Yeo, Winnie;
Mo, Frankie;
Lai, Paul;
Chan, Stephen L;
Tada, Toshifumi;
Toyoda, Hidenori;
Kumada, Takashi

Publication type:

journal article

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.

Published in:

2017

By:

Waked, Imam;
Berhane, Sarah;
Toyoda, Hidenori;
Chan, Stephen L;
Stern, Nicholas;
Palmer, Daniel;
Tada, Toshifumi;
Yeo, Winnie;
Mo, Frankie;
Bettinger, Dominik;
Kirstein, Martha M;
Iñarrairaegui, Mercedes;
Gomaa, Asmaa;
Vogel, Arndt;
Meyer, Tim;
Sangro, Bruno;
Lai, Paul;
Kumada, Takashi;
Johnson, Philip J;
Iñarrairaegui, Mercedes

Publication type:

journal article

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade.

Published in:

2016

By:

Toyoda, Hidenori;
Lai, Paul BS;
O'Beirne, James;
Chong, Charing C;
Berhane, Sarah;
Reeves, Helen;
Manas, Derek;
Fox, Richard P;
Yeo, Winnie;
Mo, Frankie;
Chan, Anthony WH;
Tada, Toshifumi;
Iñarrairaegui, Mercedes;
Vogel, Arndt;
Schweitzer, Nora;
Chan, Stephen L;
Sangro, Bruno;
Kumada, Takashi;
Johnson, Philip J;
Iñarrairaegui, Mercedes

Publication type:

journal article

Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma.

Published in:

American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 2, p. 368, doi. 10.1038/ajg.2010.432

By:

Kudo, Masatoshi;
Hatanaka, Kinuyo;
Kumada, Takashi;
Toyoda, Hidenori;
Tada, Toshifumi

Publication type:

Article

Comparison of the Usefulness of Three Staging Systems for Hepatocellular Carcinoma (CLIP, BCLC, and JIS) in Japan.

Published in:

American Journal of Gastroenterology (Springer Nature), 2005, v. 100, n. 8, p. 1764, doi. 10.1111/j.1572-0241.2005.41943.x

By:

Toyoda, Hidenori;
Kumada, Takashi;
Kiriyama, Seiki;
Sone, Yasuhiro;
Tanikawa, Makoto;
Hisanaga, Yasuhiro;
Yamaguchi, Akihiro;
Isogai, Masatoshi;
Kaneoka, Yuji;
Washizu, Junji

Publication type:

Article

Usefulness of Measurement of Lens Culinaris Agglutinin-Reactive Fraction of α-Fetoprotein as a Marker of Prognosis and Recurrence of Small Hepatocellular Carcinoma.

Published in:

American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 10, p. 3028, doi. 10.1111/j.1572-0241.1999.01378.x

By:

Hayashi, Kazuhiko;
Kumada, Takashi;
Nakano, Satoshi;
Takeda, Isao;
Sugiyama, Keiichi;
Kiriyama, Seiki;
Sone, Yasuhiro;
Miyata, Akihiro;
Shimizu, Hideyuki;
Satomura, Shinji

Publication type:

Article

Presence of Multiple Genotype-Specific Antibodies in Patients With Persistent Infection With Hepatitis C Virus (HCV) of a Single Genotype: Evidence for Transient or Occult Superinfection With HCV of Different Genotypes.

Published in:

American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 8, p. 2230, doi. 10.1111/j.1572-0241.1999.01298.x

By:

Toyoda, Hidenori;
Fukuda, Yoshihide;
Hayakawa, Tetsuo;
Kumada, Takashi;
Nakano, Satoshi;
Takamatsu, Junki;
Saito, Hidehiko

Publication type:

Article

Effect of Daily Administration Period of Natural α-Interferon in Patients with Chronic Hepatitis C.

Published in:

American Journal of Gastroenterology (Springer Nature), 1996, v. 91, n. 4, p. 743

By:

Toyoda, Hidenori;
Nakano, Satoshi;
Kumada, Takashi;
Takeda, Isao;
Sugiyama, Keiichi;
Osada, Toshimasa;
Kiriyama, Seiki

Publication type:

Article

Retreatment of Chronic Hepatitis C with Interferon.

Published in:

American Journal of Gastroenterology (Springer Nature), 1994, v. 89, n. 9, p. 1453

By:

Toyoda, Hidenori;
Nakano, Satoshi;
Takeda, Isao;
Kumada, Takashi;
Sugiyama, Keiichi;
Osada, Toshimasa;
Kiriyama, Seiki;
Suga, Takashi;
Ohki, Hayato;
Ito, Osamu;
Ebata, Mieko;
Takahashi, Mikako

Publication type:

Article

Plasma and tumoral glypican‐3 levels are correlated in patients with hepatitis C virus‐related hepatocellular carcinoma.

Published in:

Cancer Science, 2020, v. 111, n. 2, p. 334, doi. 10.1111/cas.14251

By:

Shimizu, Yasuhiro;
Mizuno, Shoichi;
Fujinami, Norihiro;
Suzuki, Toshihiro;
Saito, Keigo;
Konishi, Masaru;
Takahashi, Shinichiro;
Gotohda, Naoto;
Tada, Toshifumi;
Toyoda, Hidenori;
Kumada, Takashi;
Miura, Masahiro;
Suto, Kouzou;
Yamaji, Taiki;
Matsuda, Takahisa;
Endo, Itaru;
Nakatsura, Tetsuya

Publication type:

Article

Differences in the impact of prognostic factors for hepatocellular carcinoma over time.

Published in:

Cancer Science, 2017, v. 108, n. 12, p. 2438, doi. 10.1111/cas.13406

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi;
Yama, Tsuyoki;
Mizuno, Kazuyuki;
Sone, Yasuhiro;
Maeda, Atsuyuki;
Kaneoka, Yuji;
Akita, Tomoyuki;
Tanaka, Junko

Publication type:

Article

Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.

Published in:

Cancer Science, 2017, v. 108, n. 7, p. 1414, doi. 10.1111/cas.13257

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Itobayashi, Ei;
Nouso, Kazuhiro;
Kariyama, Kazuya;
Ishikawa, Toru;
Hirooka, Masashi;
Hiasa, Yoichi

Publication type:

Article